|
Catalog Number MV0420-0006 |
Device Problems
Complete Blockage (1094); Restricted Flow rate (1248); Leak/Splash (1354); Device Contamination with Chemical or Other Material (2944)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/03/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medical device lot #: an invalid lot # of 202040 was provided by the initial reporter.Device expiration date: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
|
|
Event Description
|
It was reported that the smartsite 20mm vented vial access device experienced flow issues, was clogged/blocked/occluded, experienced leakage, and experienced device damage/deformation while still considered operable.The following information was provided by the initial reporter: the paclitaxel vial is hit by a spike: 1st sampling does not show any problem.Then during a second sampling, it is impossible to withdraw the liquid, as the syringe plunger is inactivated (by pulling or pushing).Caution: paclitaxel leaked on the vial.No clinical consequences for the operator or the patient.
|
|
Manufacturer Narrative
|
The following fields were updated due to additional information: d4: medical device lot #: 202040.D4: medical device expiration date: unknown.H4: device manufacture date: unknown.D10: device available for eval yes.D10: returned to manufacturer on: 2021-04-13.H6: investigation summary one mv0420-0006 sample from lot 202040 was received attached to a vial access device (vad) that was inserted into a glass bottle of paclitaxel.The sample was received without packaging and with residual fluid in the device.Functional testing of the returned (b)(6) sample confirmed that the smartsite could be easily detached from the vad after manually twisting the smartsite.In addition, functional testing was performed on the smartsite with a retained 50ml bd plastipak syringe; no flow restriction or occlusion was observed throughout testing.The details of this feedback were shared with the legal manufacturer of the product, yukon medical llc, for investigation.A definitive root cause for the reported occlusion could not be determined in this instance, as no occlusion was identified during testing of the returned sample.However during the testing the smartsite was observed to have separated from the vad; a definitive root cause for the separation could not be determined in this instance, however it is possible that it occurred as a result of an inconsistent or insufficient application of glue, coupled with the force being applied to the smartsite during engagement or disengagement of the connecting product.A review of the production records from lot 202040 did not identify any in-process testing failures or quality deviations which may have resulted in a report of this nature.In order to ensure that reports of this nature are reduced, yukon medical llc, have implemented additional in-process testing during future production of this product.A review of the customer feedback database indicates that there have been no further reports for occlusion against the (b)(6) product in the past 12 months, however there have been a small number of similar reports for separation of the smartsite.
|
|
Event Description
|
It was reported that the smartsite 20mm vented vial access device experienced flow issues, was clogged/blocked/occluded, experienced leakage, and experienced device damage/deformation while still considered operable.The following information was provided by the initial reporter: the paclitaxel vial is hit by a spike: 1st sampling does not show any problem.Then during a second sampling, it is impossible to withdraw the liquid, as the syringe plunger is inactivated (by pulling or pushing).Caution: paclitaxel leaked on the vial.No clinical consequences for the operator or the patient.
|
|
Search Alerts/Recalls
|
|
|